simendan has been researched along with malondialdehyde in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Andreadou, I; Androulakis, A; Avgeropoulou, C; Demopoulou, M; Kallikazaros, I; Markantonis-Kyroudis, S; Missovoulos, P | 1 |
| Andreadou, I; Bistola, V; Filippatos, G; Iliodromitis, EK; Kremastinos, DT; Louka, A; Markantonis, SL; Paraskevaidis, I; Parissis, JT; Pyriochou, A | 1 |
| Altunkan, Z; Apa, D; Balli, E; Bilgin, E; Birbicer, H; Doruk, N; Oral, U; Ozeren, M; Tamer, L; Yapici, D | 1 |
| Aksun, M; Bahriye Lafci, B; Gurbuz, A; Ortac, R; Ozbek, C; Tulukoglu, E; Yakut, N; Yasa, H | 1 |
| Emrecan, B; Ergunes, K; Gurbuz, A; Karahan, N; Ortac, R; Ozbek, C; Yakut, N; Yasa, H | 1 |
| Basel, H; Bektas, H; Demir, H; Ekim, H; Kavak, S; Meral, I | 1 |
| Basel, H; Demir, H; Gecit, I; Gümrükçüoğlu, HA; Kavak, S; Meral, I; Yuksel, MB | 1 |
| Basel, H; Bektas, H; Demir, H; Gecit, I; Gümrükçüoglu, HA; Kavak, S; Meral, I; Yüksel, MB | 1 |
| Ay, Y; Aydin, C; Basel, H; Bektaş, H; Demir, H; Ekim, H; Gümrükçüoğlu, HA; Inan, B; Kavak, S | 1 |
| Ay, NK; Ay, Y; Aydın, C; Basel, H; Bektaş, H; Bülüt, G; Demir, I; Inan, B | 1 |
| Akhtar, M; Akhtar, MS; Ali, J; Ansari, SH; Hassan, Q; Najmi, AK; Pillai, KK | 1 |
| Askin, S; Ekinci Akdemir, FN; Eser, G; Gozeler, MS; Sahin, A; Yildirim, S | 1 |
| Fu, M; Liu, Y; Wang, Z | 1 |
| Akyol, ME; Aycan, A; Ergur, B; Gonullu, E; Kume, T; Kuyumcu, F; Oksuz, E; Tas, A | 1 |
3 trial(s) available for simendan and malondialdehyde
| Article | Year |
|---|---|
The Ca2+-sensitizer levosimendan improves oxidative damage, BNP and pro-inflammatory cytokine levels in patients with advanced decompensated heart failure in comparison to dobutamine.
Topics: Adrenergic beta-Agonists; Aged; Aged, 80 and over; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Interleukin-6; Male; Malondialdehyde; Middle Aged; Natriuretic Peptide, Brain; Oxidative Stress; Pyridazines; Simendan; Time Factors; Tumor Necrosis Factor-alpha | 2005 |
Effects of Levosimendan on circulating markers of oxidative and nitrosative stress in patients with advanced heart failure.
Topics: Aged; Anti-Arrhythmia Agents; Female; Heart Failure; Humans; Hydrazones; Male; Malondialdehyde; Middle Aged; Nitric Oxide; Oxidative Stress; Protein Carbonylation; Pyridazines; Simendan; Stroke Volume; Tyrosine | 2007 |
Effects of Xinkeshu combined with levosimendan on perioperative heart failure in oldest-old patients with hip fractures.
Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Drugs, Chinese Herbal; Endothelin-1; Female; Heart Failure; Hip Fractures; Humans; Male; Malondialdehyde; Natriuretic Peptide, Brain; Nitric Oxide; Simendan; Treatment Outcome | 2020 |
11 other study(ies) available for simendan and malondialdehyde
| Article | Year |
|---|---|
Effects of levosimendan on myocardial ischaemia-reperfusion injury.
Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Hydrazones; Male; Malondialdehyde; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; Peroxidase; Pyridazines; Rats; Rats, Wistar; Simendan; Sodium-Potassium-Exchanging ATPase | 2008 |
The influence of levosimendan and iloprost on renal ischemia-reperfusion: an experimental study.
Topics: Animals; Atrophy; Disease Models, Animal; Female; Hydrazones; Iloprost; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Malondialdehyde; Necrosis; Protective Agents; Pyridazines; Rabbits; Reperfusion Injury; Simendan | 2008 |
Protective effects of levosimendan and iloprost on lung injury induced by limb ischemia-reperfusion: a rabbit model.
Topics: Animals; Disease Models, Animal; Extremities; Female; Hydrazones; Iloprost; Lung; Male; Malondialdehyde; Pyridazines; Rabbits; Reperfusion Injury; Simendan | 2008 |
Effect of levosimendan injection on oxidative stress of rat myocardium.
Topics: Animals; Antioxidants; Carbonic Anhydrases; Cardiotonic Agents; Catalase; Glutathione; Glutathione Peroxidase; Heart; Hydrazones; Injections, Intraperitoneal; Lipid Peroxidation; Male; Malondialdehyde; Myocardium; Oxidative Stress; Pyridazines; Random Allocation; Rats; Rats, Wistar; Simendan; Statistics, Nonparametric; Superoxide Dismutase | 2013 |
Short-term levosimendan treatment protects rat testes against oxidative stress.
Topics: Animals; Antioxidants; Glutathione Peroxidase; Hydrazones; Male; Malondialdehyde; Oxidative Stress; Pyridazines; Random Allocation; Rats; Rats, Wistar; Reactive Oxygen Species; Simendan; Superoxide Dismutase; Trace Elements | 2012 |
Effect of short-term treatment with levosimendan on oxidative stress in renal tissues of rats.
Topics: Animals; Antioxidants; Glutathione; Hydrazones; Kidney; Male; Malondialdehyde; Oxidative Stress; Oxidoreductases; Pyridazines; Rats; Rats, Wistar; Simendan | 2014 |
Analysis of the influences of short-term levosimendan exposure on oxidant/antioxidant status and trace-element levels in the physiological status of the thoracic aorta of rats.
Topics: Animals; Aorta, Thoracic; Cardiotonic Agents; Catalase; Free Radicals; Glutathione; Glutathione Peroxidase; Hydrazones; Lipid Peroxidation; Male; Malondialdehyde; Oxidation-Reduction; Oxidative Stress; Pyridazines; Rats; Rats, Wistar; Simendan; Superoxide Dismutase; Time Factors; Trace Elements | 2012 |
The effects of levosimendan exposure on oxidant/antioxidant status and trace element levels in the pulmonary artery of rats.
Topics: Animals; Anti-Arrhythmia Agents; Antioxidants; Free Radicals; Glutathione; Hydrazones; Male; Malondialdehyde; Oxidants; Oxidoreductases; Pulmonary Artery; Pyridazines; Rats; Rats, Wistar; Simendan; Trace Elements | 2013 |
Levosimendan suppresses oxidative injury, apoptotic signaling and mitochondrial degeneration in streptozotocin-induced diabetic cardiomyopathy.
Topics: Animals; Apoptosis; C-Reactive Protein; Cardiotonic Agents; Caspase 3; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Glutathione Peroxidase; Hydrazones; Hypoglycemic Agents; Insulin; Male; Malondialdehyde; Oxidative Stress; Pyridazines; Ramipril; Rats; Rats, Wistar; Simendan; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2016 |
Levosimendan ameliorates cisplatin-induced ototoxicity: Rat model.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Cisplatin; Cochlea; Deoxyguanosine; Disease Models, Animal; Female; Glutathione Peroxidase; Hearing; Hearing Loss; Malondialdehyde; Otoacoustic Emissions, Spontaneous; Oxidative Stress; Phosphodiesterase 3 Inhibitors; Random Allocation; Rats; Rats, Sprague-Dawley; Signal-To-Noise Ratio; Simendan; Superoxide Dismutase | 2019 |
A New Approach in the Treatment of Traumatic Brain Injury: The Effects of Levosimendan on Necrosis, Apoptosis, and Oxidative Stress.
Topics: Animals; Apoptosis; Brain Injuries, Traumatic; Caspase 3; Catalase; Female; Malondialdehyde; Necrosis; Oxidative Stress; Rats; Rats, Wistar; Simendan; Superoxide Dismutase | 2022 |